Lansoprazol Viatris

Lansoprazole, the active ingredient in Lansoprazol Viatris, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is prescribed for conditions such as gastro‑oesophageal reflux disease, duodenal ulcer and Zollinger‑Ellison syndrome in adults and, when appropriate, in pediatric patients.

GNH USA supplies Lansoprazol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and relieves heartburn and regurgitation. - Erosive esophagitis: promotes healing of inflamed esophageal tissue. - Duodenal ulcer: facilitates ulcer healing by lowering gastric acidity. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, often transient. - Abdominal pain: discomfort or cramping. - Nausea: feeling of sickness. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema). - Clostridioides difficile‑associated colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: potential hepatic injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute pancreatitis: inflammation of the pancreas.

Before initiating therapy, consider the following precautions.

- Assess renal function: adjust use in severe renal impairment. - Monitor for infection: prolonged therapy may increase risk of gastrointestinal infections. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Use caution in pregnancy: only if the potential benefit justifies the potential risk to the fetus. - Store at room temperature: keep in the original container, protect from moisture and heat.

Lansoprazole may interact with several medicines; categorize interactions by clinical significance.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased serum concentration. - High‑dose methotrexate: increased toxicity. - Ketoconazole: decreased absorption of ketoconazole. - Warfarin: variable INR changes.

Moderate Interactions (Monitor Closely): - Digoxin: possible increased levels. - Diazepam: enhanced sedation. - Iron salts: reduced iron absorption. - Vitamin B12: decreased absorption with long‑term use. - HIV protease inhibitors: altered plasma levels.